Company news
Cyclopharm Limited (ASX:CYC) news
Cyclopharm Limited news releases on 6ix. Latest, Aug 23, 2026: CYC 1H2026 Results Summary
Press releases & updates
CYC 1H2026 Results Summary
August 23, 2026
New US Lung Imaging Guidelines Name Technegas as Preferred A
July 28, 2026
Immediate 11-Site Technegas Rollout at University Hospitals
July 14, 2026
CYC First-Half 2026 Update
July 1, 2026
USA Technegas Expansion Update
March 30, 2026
CYC Secures Multi-Site Agreement with Northwestern Medicine
March 23, 2026
CYC Signs Enterprise Agreement with UPHS
March 22, 2026
Preliminary Final Report
February 25, 2026
Technegas US Footprint Expanding Across Four Regions
February 19, 2026
Technegas Approved at the US National Institutes of Health
February 18, 2026
Cyclopharm Capital Raising Investor Presentation
February 3, 2026
Cyclopharm Successfully Completes A$14 million Placement
February 3, 2026
CYC Unaudited Trading Update - Preliminary FY2025 Results
February 1, 2026
Trading Halt
February 1, 2026
COPD Study Leveraging Technegas and AI-Driven Lung Analysis
January 28, 2026
Technegas Recognised in Updated Clinical Guideline
January 26, 2026
Insurer Indemnifies Cyclopharm
January 26, 2026
Stanford Children's Health to Implement Technegas
January 11, 2026
Colombia Approval Marks 67th Country for Technegas
December 21, 2025
Cyclopharm Bell Potter Healthcare Conference Presentation
November 18, 2025
Legal Proceedings
October 7, 2025
S&P DJI Announces September 2025 Quarterly Rebalance
September 5, 2025
CYC 1H2025 Results Summary
August 27, 2025
Half Yearly Report and Accounts
August 27, 2025
Cyclopharm Secures Maximum US Patent Extension for Technegas
June 10, 2025
Technegas US Momentum Accelerates with $US1m Sales Milestone
March 31, 2025
Company Update
March 18, 2025
CYC signs 5-year Agreement with USA Veterans Administration
March 13, 2025
CYC Results Summary
February 24, 2025
CYC Signs US National Agreement with HCA for Technegas
January 22, 2025
Response to ASX Price Query
January 6, 2025
Cyclopharm's USA Technegas Expansion Update
December 20, 2024
US Clinical Paper - Technegas for Lung Transplant Evaluation
December 8, 2024
First Patients Imaged with Technegas - French Clinical Trial
December 2, 2024
CYC Receives First Technegas Orders from US VA Hospitals
November 27, 2024
CYC Signs Agreement with VA and First DoD Order Received
October 3, 2024
Cyclopharm - 2024 First Half Results & USA Expansion Update
September 2, 2024
Cyclopharm 2024 H1 Trading and USA Expansion Update
August 26, 2024
Cyclopharm completes oversubscribed Share Purchase Plan
June 24, 2024
USA Reimbursement Update for TECHNEGAS
June 23, 2024
Cyclopharm Presenting at Macquarie Emerging Leaders Conf
June 18, 2024
TECHNEGAS Awarded US Pass-Through Reimbursemt Status
June 5, 2024
Cyclopharm Successfully Completes A$20.0 Million Placement
May 27, 2024
Cyclopharm Capital Raising
May 24, 2024
Cyclopharm Capital Raising Presentation
May 24, 2024
Cyclopharm Business Update
May 5, 2024
First USA Patients Imaged with Technegas
March 18, 2024
S&P DJI Announces March 2024 Quarterly Rebalance
March 1, 2024
Cyclopharm to Present at Euroz Hartleys Healthcare Forum
February 5, 2024
Cyclopharm Trading and USA Launch Update
February 5, 2024